<DOC>
	<DOCNO>NCT01813344</DOCNO>
	<brief_summary>Treatment outcomes lymphoblastic lymphoma ( LBL ) improve use regimens acute lymphoblastic leukemia . Hyper-CVAD one effective treatment high remission rate acute lymphoblastic leukemia ( ALL ) LBL . However , treatment outcome hyper-CVAD LBL report small number patient single institution . The investigator conduct study evaluate hyper-CVAD regimen base treatment LBL .</brief_summary>
	<brief_title>Hyper-CVAD Treatment Lymphoblastic Lymphoma</brief_title>
	<detailed_description>We analyze treatment outcome lymphoblastic lymphoma patient treat hyper-CVAD regimen 13 institution Korea . In patient , hyper-CVAD initial treatment . After achievement response , patient either underwent hematopoietic stem cell transplantation ( HSCT ) consolidation hyper-CVAD .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>age 18 diagnosis Pathologically proven lymphoblastic lymphoma proven HIV infection pretreatment regimen</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Adult lymphoblastic lymphoma</keyword>
	<keyword>Hyper-CVAD</keyword>
	<keyword>first-line treatment</keyword>
</DOC>